Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)

Live and On-Demand Activities

Filter Activities


Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency

1.50 hr(s) | CME

Specialty: Genetics

Therapeutic Area(s): Cardiology , Endocrinology , Genetics / genetic disorders , Hematology, Benign , Hepatology , Pediatrics , Pulmonology

Release Date: June 4, 2020

Expiration Date: June 3, 2021

Location: Internet Activity Enduring

Chronic visceral acid sphingomyelinase deficiency (ASMD), also referred to as Niemann-Pick disease type B, is a rare and progressive autosomal recessive lysosomal storage disorder that causes progressive accumulation of sphingomyelin and other lipids in tissues throughout the body and is associated with significant morbidity and reduced life expectancy. The diagnosis of chronic visceral ASMD is often delayed by months or years, because its complex signs and symptoms overlap with other diseases. In this activity, leading experts review current consensus recommendations for the diagnosis of ASMD in pediatric and adult patients. The faculty also review the latest safety, efficacy, and tolerability data on emerging therapies and explore patient cases to offer practical strategies on how to optimally manage patients with chronic visceral ASMD.

Achieving Consensus on Modern VOD/SOS Management: A Guide to Disease Recognition, Classification, and Treatment in Adults and Pediatric Patients

0.75 hr(s) | CME

Specialty: Oncology , SOS , VOD

Therapeutic Area(s): Hematology, Benign , Oncology , Transplant

Release Date: June 4, 2020

Expiration Date: June 3, 2021

Location: Internet Activity Enduring

In this activity, an expert in hematology discusses the recognition, classification, and treatment of adult and pediatric patients with veno-occlusive disease and sinusoidal obstruction syndrome.


1.5 hr(s) | NCPD

Therapeutic Area(s): CAR T

Release Date: January 19, 2021

Expiration Date: January 19, 2022

Location: Internet Activity Enduring Material

Nurses from three cancer centers discuss the nurse's role in preparing patients and caregivers for the CAR T-cell treatment process, assessment, monitoring for and managing side effects, and communication with the patient's community healthcare team to transition patient care back. Following a patient from initial treatment discussion, participants will be able to provide patient care for the case, in this interactive session. With CAR T-cell therapy and follow-up care expanding beyond the major centers, nurses are essential members of the treatment team.

Advances in Treatment for Chronic Lymphocytic Leukemia (CLL)

1.50 hr(s) | No CE Offered , Patient Education

Specialty: Leukemia

Therapeutic Area(s): Chronic Lympoblastic Leukemia (CLL) , Hematology, Benign

Release Date: April 7, 2021

Expiration Date: April 7, 2021

Location: TeleWeb

This telephone and web presentation for patients and caregivers will occur on April 7, 2021 from 1:00 pm to 2:30 pm Eastern Time.

1 14 15 16
Copy link
Powered by Social Snap